Aside from utilizing chronotherapy as a therapeutic approach, the group found that the CLOCK level was downregulated in ALDH+ cells in the murine 4T1 breast cancer cells, and overexpression of CLOCK markedly inhibited the tumorigenicity and invasive capacities of these breast cancer cells. The gene discussed is CLOCK; the disease is breast cancer.